Get the Stockscreener App
10.19
0.65%
-0.07
Dynavax Technologies Corp stock is traded at $10.19, with a volume of 688.71K.
It is down -0.65% in the last 24 hours and up +0.92% over the past month.
Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.
See More
Previous Close:
$10.26
Open:
$10.22
24h Volume:
688.71K
Relative Volume:
0.42
Market Cap:
$1.20B
Revenue:
$260.81M
Net Income/Loss:
$20.48M
P/E Ratio:
78.38
EPS:
0.13
Net Cash Flow:
$22.67M
1W Performance:
-2.83%
1M Performance:
+0.92%
6M Performance:
-10.03%
1Y Performance:
-13.47%
1-Day Range:
$10.10
$10.34
1-Week Range:
$10.10
$10.58
52-Week Range:
$9.20
$14.63
Dynavax Technologies Corp Stock (DVAX) Company Profile
Name
Dynavax Technologies Corp
Sector
Phone
(510) 848-5100
Address
2100 POWELL STREET, EMERYVILLE, CA
Compare DVAX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DVAX
Dynavax Technologies Corp
|
10.20 | 1.20B | 260.81M | 20.48M | 22.67M | 0.13 |
|
ZTS
Zoetis Inc
|
144.38 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.43 | 42.46B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.385 | 41.28B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.49 | 23.49B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
436.34 | 19.18B | 3.08B | 1.24B | 1.07B | 25.61 |
Dynavax Technologies Corp Stock (DVAX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-11-25 | Downgrade | Goldman | Neutral → Sell |
| Feb-01-24 | Initiated | Goldman | Neutral |
| Sep-27-22 | Initiated | JMP Securities | Mkt Outperform |
| Jan-06-22 | Resumed | Goldman | Buy |
| Aug-06-21 | Initiated | Goldman | Buy |
| Aug-07-20 | Reiterated | H.C. Wainwright | Buy |
| Aug-03-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-15-20 | Initiated | Evercore ISI | Outperform |
| Oct-18-19 | Initiated | H.C. Wainwright | Buy |
| Jul-11-19 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Feb-27-19 | Reiterated | Cantor Fitzgerald | Overweight |
| May-10-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Mar-08-18 | Reiterated | Cantor Fitzgerald | Overweight |
| Feb-14-18 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-25-17 | Reiterated | RBC Capital Mkts | Outperform |
| Sep-15-17 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-31-17 | Upgrade | JP Morgan | Neutral → Overweight |
| Jul-31-17 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| May-09-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Apr-28-16 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Apr-27-16 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-30-15 | Initiated | RBC Capital Mkts | Outperform |
| Nov-25-13 | Upgrade | MLV & Co | Hold → Buy |
| Feb-25-13 | Downgrade | MLV & Co | Buy → Hold |
| Nov-16-12 | Reiterated | MLV & Co | Buy |
View All
Dynavax Technologies Corp Stock (DVAX) Latest News
What MACD and RSI say about Dynavax Technologies CorporationDay Trade & Weekly Return Optimization Plans - newser.com
What institutional flow reveals about Dynavax Technologies CorporationJuly 2025 Market Mood & Weekly Setup with High ROI Potential - newser.com
Will Dynavax Technologies Corporation (DYF1) stock benefit from Fed rate cutsWeekly Trade Recap & Entry Point Confirmation Alerts - newser.com
Will Dynavax Technologies Corporation (DYF1) stock deliver compounding returns2025 Volatility Report & Real-Time Buy Zone Alerts - newser.com
Can Dynavax Technologies Corporation stock reach $100 price targetTrade Risk Assessment & Low Volatility Stock Recommendations - newser.com
Using data tools to time your Dynavax Technologies Corporation exitJuly 2025 Sector Moves & Verified Stock Trade Ideas - newser.com
139,227 Shares in Dynavax Technologies Corporation $DVAX Purchased by Y Intercept Hong Kong Ltd - MarketBeat
What dividend safety score for Dynavax Technologies Corporation stockVolume Spike & Technical Confirmation Trade Alerts - newser.com
Will Dynavax Technologies Corporation stock remain a Wall Street favorite2025 Volatility Report & Smart Allocation Stock Tips - newser.com
Will Dynavax Technologies Corporation stock maintain dividend yieldMarket Movement Recap & Detailed Earnings Play Alerts - newser.com
What sentiment indicators say about Dynavax Technologies Corporation stockSell Signal & High Yield Stock Recommendations - newser.com
Strategies to average down on Dynavax Technologies Corporation2025 Trading Recap & AI Enhanced Trading Signals - newser.com
Will Dynavax Technologies Corporation (DYF1) stock deliver stable dividends2025 Market Outlook & Low Risk Profit Maximizing Plans - newser.com
Why Dynavax Technologies Corporation stock is popular among millennialsWeekly Gains Summary & Free Technical Pattern Based Buy Signals - newser.com
Predicting Dynavax Technologies Corporation trend using moving averagesJuly 2025 PreEarnings & Stepwise Entry and Exit Trade Signals - newser.com
Chart overlay techniques for tracking Dynavax Technologies CorporationMarket Trend Review & Fast Exit Strategy with Risk Control - newser.com
Using data models to predict Dynavax Technologies Corporation stock movement2025 Analyst Calls & Weekly Watchlist of Top Performers - newser.com
Published on: 2025-10-31 00:23:52 - newser.com
How Dynavax Technologies Corporation stock performs after earnings2025 Valuation Update & Fast Exit/Entry Strategy Plans - newser.com
Dynavax Technologies (DVAX) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
How interest rate cuts could boost Dynavax Technologies Corporation stockEarnings Beat & High Accuracy Swing Trade Signals - newser.com
Will Dynavax Technologies Corporation price bounce be sustainableDay Trade & AI Powered Market Trend Analysis - newser.com
Dynavax Technologies Corporatio (DVAX) Stock Forecasts - Yahoo Finance
Dynavax Technologies Corporation (DVAX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Dynavax Technologies Corporation (NASDAQ:DVAX) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Dynavax Technologies Corp Stock (DVAX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Dynavax Technologies Corp Stock (DVAX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Deep Track Biotechnology Maste | 10% Owner |
Aug 21 '25 |
Sale |
11.03 |
1,094,994 |
12,077,784 |
16,696,492 |
| Deep Track Biotechnology Maste | 10% Owner |
Aug 22 '25 |
Sale |
10.59 |
970,143 |
10,273,814 |
15,726,349 |
| Novack David F | President & COO |
Mar 24 '25 |
Option Exercise |
6.80 |
10,000 |
68,050 |
18,078 |
| Novack David F | President & COO |
Mar 24 '25 |
Sale |
14.00 |
10,000 |
140,000 |
8,078 |
1.17%
1.30%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):